http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008535504-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-53 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2006-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008535504-A |
| titleOfInvention | Use of RNAi-based approaches targeting galectin-1 to treat cancer |
| abstract | The present invention relates to an RNAi molecule suitable for reducing the expression of galectin-1 comprising the sequence of SEQ ID NO: 1-33, preferably any of the sequences of SEQ ID NO: 2, 3, or 4, its use as a medicament, Alternatively, an RNAi molecule suitable for producing a medicament for treating and / or delaying progression of cancer, preferably glioma, pancreatic cancer, head and neck cancer, melanoma, non-small cell lung cancer, and non-Hodgkin lymphoma About. The present invention also treats cancer, preferably glioma, pancreatic cancer, head and neck cancer, melanoma, non-small cell lung cancer, and non-Hodgkin lymphoma, delays progression, tumor cells, preferably glioma, pancreatic cancer Reducing cell migration of head and neck cancer, melanoma, non-small cell lung cancer, and non-Hodgkin lymphoma and / or selected from the group comprising chemotherapy, radiation therapy, immunotherapy, and / or gene therapy, It relates to compositions and methods for increasing the efficiency of cancer therapies for treating cancer, preferably glioma, pancreatic cancer, head and neck cancer, melanoma, non-small cell lung cancer, and non-Hodgkin lymphoma. [Selection figure] None |
| priorityDate | 2005-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.